Synopsys, Inc. $SNPS Shares Purchased by Comprehensive Financial Consultants Institutional Inc.

Comprehensive Financial Consultants Institutional Inc. boosted its holdings in shares of Synopsys, Inc. (NASDAQ:SNPS) by 42.4% in the 3rd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 4,643 shares of the semiconductor company’s stock after acquiring an additional 1,383 shares during the period. Comprehensive Financial Consultants Institutional Inc.’s holdings in Synopsys were worth $2,291,000 at the end of the most recent reporting period.

A number of other institutional investors have also bought and sold shares of SNPS. Saudi Central Bank purchased a new stake in shares of Synopsys in the first quarter valued at approximately $26,000. Independence Bank of Kentucky lifted its position in Synopsys by 120.0% during the second quarter. Independence Bank of Kentucky now owns 55 shares of the semiconductor company’s stock worth $28,000 after buying an additional 30 shares in the last quarter. Princeton Global Asset Management LLC boosted its stake in Synopsys by 481.8% during the second quarter. Princeton Global Asset Management LLC now owns 64 shares of the semiconductor company’s stock worth $33,000 after buying an additional 53 shares during the last quarter. WPG Advisers LLC acquired a new position in Synopsys during the first quarter worth $34,000. Finally, AlphaQuest LLC grew its holdings in Synopsys by 423.1% in the 2nd quarter. AlphaQuest LLC now owns 68 shares of the semiconductor company’s stock valued at $35,000 after buying an additional 55 shares in the last quarter. 85.47% of the stock is owned by hedge funds and other institutional investors.

Wall Street Analyst Weigh In

SNPS has been the topic of several analyst reports. Stifel Nicolaus reduced their price target on Synopsys from $650.00 to $550.00 and set a “buy” rating on the stock in a report on Wednesday, September 10th. Zacks Research raised shares of Synopsys from a “strong sell” rating to a “hold” rating in a research note on Monday, November 10th. Bank of America raised shares of Synopsys from an “underperform” rating to a “neutral” rating and dropped their price target for the company from $525.00 to $500.00 in a research note on Monday, December 8th. Robert W. Baird restated a “neutral” rating and set a $535.00 price target (down previously from $670.00) on shares of Synopsys in a report on Wednesday, September 10th. Finally, Needham & Company LLC upped their price objective on Synopsys from $550.00 to $580.00 and gave the company a “buy” rating in a report on Thursday, December 11th. Eleven investment analysts have rated the stock with a Buy rating, six have assigned a Hold rating and one has assigned a Sell rating to the company’s stock. According to MarketBeat, Synopsys has an average rating of “Moderate Buy” and an average price target of $562.13.

Insider Activity

In related news, CFO Shelagh Glaser sold 3,657 shares of the stock in a transaction dated Friday, December 19th. The stock was sold at an average price of $460.77, for a total transaction of $1,685,035.89. Following the transaction, the chief financial officer owned 17,842 shares of the company’s stock, valued at approximately $8,221,058.34. This represents a 17.01% decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Corporate insiders own 0.62% of the company’s stock.

Synopsys Price Performance

Synopsys stock opened at $477.14 on Friday. The company’s 50 day simple moving average is $437.58 and its 200-day simple moving average is $503.61. The company has a debt-to-equity ratio of 0.48, a quick ratio of 1.52 and a current ratio of 1.62. Synopsys, Inc. has a 1 year low of $365.74 and a 1 year high of $651.73. The company has a market capitalization of $91.29 billion, a price-to-earnings ratio of 59.72, a price-to-earnings-growth ratio of 3.96 and a beta of 1.16.

Synopsys (NASDAQ:SNPS) last posted its earnings results on Wednesday, December 10th. The semiconductor company reported $2.90 earnings per share for the quarter, beating the consensus estimate of $2.79 by $0.11. The firm had revenue of $2.25 billion during the quarter, compared to the consensus estimate of $2.25 billion. Synopsys had a net margin of 18.89% and a return on equity of 7.89%. The firm’s revenue for the quarter was up 37.8% on a year-over-year basis. During the same quarter last year, the firm earned $3.40 EPS. Synopsys has set its FY 2026 guidance at 14.320-14.400 EPS and its Q1 2026 guidance at 3.520-3.580 EPS. As a group, equities research analysts expect that Synopsys, Inc. will post 10.64 earnings per share for the current year.

Synopsys News Roundup

Here are the key news stories impacting Synopsys this week:

• Positive Sentiment: Analysts/commentary note Synopsys’ recent bounce and argue the shares could be attractive after the pullback; these narratives can support buying interest as investors re-evaluate valuation and growth prospects. Is Synopsys (SNPS) an Attractive Investment Choice?
• Positive Sentiment: Separate coverage focuses on an ~18% share rebound, asking whether the recovery leaves the stock undervalued — this kind of coverage can support momentum buyers. Synopsys (SNPS): Has the Recent 18% Share Price Rebound Left the Stock Undervalued?
• Neutral Sentiment: Reported short-interest data appears to show a 0-share figure and 0.0 days-to-cover — likely a data glitch and not a reliable signal for positioning. Treat this as non-actionable until confirmed by an exchange/shorts report.
• Negative Sentiment: Multiple law firms have announced class-action suits or investor alerts alleging securities fraud tied to a sharp prior stock drop; firms are soliciting lead plaintiffs with a looming Dec. 30, 2025 deadline. The alleged class period is Dec. 4, 2024 through Sept. 9, 2025; some filings cite a ~36% decline as the basis for claims. This concentrated legal publicity increases headline risk, potential litigation costs, and investor uncertainty — factors that can pressure the stock. Representative notices: KSF / Charles Foti 96-Hour Deadline Alert — BFA: Suit after 36% stock drop — Levi & Korsinsky notice

Synopsys Profile

Synopsys, Inc is a leading provider of electronic design automation (EDA) software and semiconductor intellectual property (IP) used to design, verify and manufacture integrated circuits and complex systems-on-chip (SoCs). Its product portfolio spans tools and technologies for front‑end design and synthesis, simulation and verification, physical implementation and signoff, and design-for-manufacturability, enabling chip designers to move from architecture through tape‑out.

In addition to core EDA offerings, Synopsys supplies a broad set of semiconductor IP building blocks — such as interface, memory and analog/mixed-signal cores — that customers integrate into SoCs to accelerate development.